Chemical inhibitors of interferon-gamma-inducible GTPase 10 (Gm12250) have been meticulously selected based on their potential interactions with GTPase-related pathways and mechanisms. The objective behind choosing these inhibitors is to indirectly inhibit the functional activity of Gm12250 by targeting various GTPases and the regulatory molecules associated with them. Among the selected inhibitors, which include NSC23766, ML141, SecinH3, CID-1067700, Brefeldin A, 1A116, ZCL278, ITX3, EHT 1864, CASIN, and Rhosin, the primary focus is on inhibiting Rac1, Cdc42, ARF GTPases, and RhoA, along with molecules that play pivotal roles in the regulation of these GTPases. These specific targets have been chosen due to the functional similarities they share with interferon-gamma-inducible GTPase 10, which is a member of the GTPase family. By inhibiting these related GTPases and their regulatory counterparts, there is a potential to impact the pathways and cellular processes in which Gm12250 is actively involved, thereby achieving indirect inhibition.
It is important to note that while the precise pathway involvement and functional mechanisms of Gm12250 have not been fully characterized, the approach of targeting these GTPase-related mechanisms is both logical and scientifically sound. This strategy allows for the exploration of potential interactions and dependencies between Gm12250 and the selected GTPases and regulatory molecules. Through the inhibition of these interconnected components, there is an opportunity to shed light on the functional roles of Gm12250 and its significance within the broader context of cellular signaling and regulation. In essence, the careful selection of chemical inhibitors with a focus on GTPase-related pathways represents a strategic and rational approach to investigate the functional implications of Gm12250 inhibition. It underscores the importance of considering the interplay between proteins within a specific family and their potential contributions to cellular processes. This endeavor not only advances our understanding of Gm12250 but also opens up new avenues for research into the intricate world of GTPase-mediated signaling and its relevance in cellular biology.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
ML 141 | 71203-35-5 | sc-362768 sc-362768A | 5 mg 25 mg | $137.00 $512.00 | 7 | |
ML141 is a Cdc42 GTPase inhibitor, potentially influencing pathways or processes that interferon-gamma-inducible GTPase 10 is involved in, due to the shared functional features among GTPases. | ||||||
SecinH3 | 853625-60-2 | sc-203260 | 5 mg | $278.00 | 6 | |
SecinH3 inhibits cytohesins, impacting ARF GTPase signaling. This could indirectly affect interferon-gamma-inducible GTPase 10's activity by altering ARF GTPase-related pathways. | ||||||
2-(Benzoylcarbamothioylamino)-5,5-dimethyl-4,7-dihydrothieno[2,3-c]pyran-3-carboxylic Acid | 314042-01-8 | sc-503400 | 10 mg | $300.00 | ||
A general GTPase inhibitor that may indirectly inhibit interferon-gamma-inducible GTPase 10 by targeting shared mechanisms and pathways among various GTPases. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A disrupts ARF GTPase function, potentially influencing cellular processes or signaling pathways where interferon-gamma-inducible GTPase 10 is active. | ||||||
ZCL278 | 587841-73-4 | sc-507369 | 10 mg | $115.00 | ||
ZCL278 targets Cdc42 GTPase, potentially influencing pathways or cellular processes relevant to interferon-gamma-inducible GTPase 10 due to the functional similarities in GTPase family. | ||||||
ITX 3 | 347323-96-0 | sc-295214 sc-295214A | 10 mg 50 mg | $145.00 $615.00 | ||
ITX3 inhibits Trio, a guanine nucleotide exchange factor for Rac1, which could indirectly affect interferon-gamma-inducible GTPase 10 by disrupting Rac1-related pathways. | ||||||
EHT 1864 | 754240-09-0 | sc-361175 sc-361175A | 10 mg 50 mg | $213.00 $889.00 | 12 | |
EHT 1864 is a Rac1 inhibitor, potentially affecting pathways and regulatory mechanisms related to interferon-gamma-inducible GTPase 10 due to similarities in GTPase activities. | ||||||
CASIN | 425399-05-9 | sc-397016 | 10 mg | $460.00 | 1 | |
CASIN inhibits Cdc42, which might indirectly influence the activity of interferon-gamma-inducible GTPase 10 through shared GTPase pathways and processes. | ||||||
Rhosin | 1173671-63-0 | sc-507401 | 25 mg | $555.00 | ||
Rhosin, a RhoA inhibitor, could indirectly inhibit interferon-gamma-inducible GTPase 10 by affecting RhoA-related pathways that may intersect with Gm12250's functions. | ||||||